Gilda Aiello

Dr. Gilda Aiello

Department of Human Science and Quality of Life Promotion, University San Raffaele, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Functional Foods
Verified
Journal Article
Closed access
Carmen LammiCarmen Lammi
Carmen Lammi
Gilda AielloGilda Aiello
Gilda Aiello
GBGiovanna Boschin
Giovanna Boschin
AAAnna Arnoldi
Anna Arnoldi

14 November 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Gilda AielloGilda Aiello
Gilda Aiello
CLCarmen Lammi
Carmen Lammi
GBGiovanna Boschin
Giovanna Boschin
CZChiara Zanoni
Chiara Zanoni
Anna ArnoldiAnna Arnoldi
Anna Arnoldi

26 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
SBSara Baldelli
Sara Baldelli
Gilda AielloGilda Aiello
Gilda Aiello
EMEliana Mansilla Di Martino
Eliana Mansilla Di Martino
Diego CampaciDiego Campaci
Diego Campaci
FMFares M. S. Muthanna
Fares M. S. Muthanna
Mauro LombardoMauro Lombardo
Mauro Lombardo
Adipose tissue (AT), composed mainly of adipocytes, plays a critical role in lipid control, metabolism, and energy storage. Once considered metabolically inert, AT is now recognized as a dynamic endocrine organ that regulates food intake, energy homeostasis, insulin sensitivity, thermoregulation, and immune responses. This review examines the multifaceted role of adiponectin, a predominant adipokine released by AT, in glucose and fatty acid metabolism. We explore the regulatory mechanisms of adiponectin, its physiological effects and its potential as a therapeutic target for metabolic diseases such as type 2 diabetes, cardiovascular disease and fatty liver disease. Furthermore, we analyze the impact of various dietary patterns, specific nutrients, and physical activities on adiponectin levels, highlighting strategies to improve metabolic health. Our comprehensive review provides insights into the critical functions of adiponectin and its importance in maintaining systemic metabolic homeostasis.

1 September 2016 in Journal of Proteomics
Verified
Journal Article
Closed access
Gilda AielloGilda Aiello
Gilda Aiello
EFElisa Fasoli
Elisa Fasoli
GBGiovanna Boschin
Giovanna Boschin
CLCarmen Lammi
Carmen Lammi
CZChiara Zanoni
Chiara Zanoni
Anna ArnoldiAnna Arnoldi
Anna Arnoldi

18 July 2016 in Scientific Reports
Verified
Journal Article
Open access
CLCarmen Lammi
Carmen Lammi
CZChiara Zanoni
Chiara Zanoni
Gilda AielloGilda Aiello
Gilda Aiello
Anna ArnoldiAnna Arnoldi
Anna Arnoldi
Giovanni GraziosoGiovanni Grazioso
Giovanni Grazioso
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been recently identified as a new useful target for hypercholesterolemia treatment. This work demonstrates that natural peptides, deriving from the hydrolysis of lupin protein and absorbable at intestinal level, are able to inhibit the protein-protein interaction between PCSK9 and the low density lipoprotein receptor (LDLR). In order to sort out the best potential inhibitors among these peptides, a refined in silico model of the PCSK9/LDLR interaction was developed. Docking, molecular dynamics (MD) simulations and peptide binding energy estimations, by MM-GBSA approach, permitted to select the two best candidates among tested peptides that were synthesized and evaluated for their inhibitory activity. The most active was P5 that induced a concentration dependent inhibition of the PCSK9-LDLR binding, with an IC50 value equal to 1.6 ± 0.33 μM. Tested at a 10 μM concentration, this peptide increased by 66 ± 21.4% the ability of HepG2 cells to take up LDL from the extracellular environment.

2 October 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CZChiara Zanoni
Chiara Zanoni
Gilda AielloGilda Aiello
Gilda Aiello
Anna ArnoldiAnna Arnoldi
Anna Arnoldi
CLCarmen Lammi
Carmen Lammi